藻胆蛋白色素肽与癌光啉光敏作用的比较实验

目的：比较藻胆蛋白色素肽与癌光啉photofrinⅡ的光动力学疗法（photodynamic therapy,PDT）效果与日光光敏作用.方法：分析藻胆蛋白酶解产物藻红蛋白R-PE β亚基、藻蓝蛋白的CCP1、CCP3片段与photofrinⅡ的光谱特性,用MTT等方法检测其对小鼠S180细胞、小鼠移植瘤的PDT杀伤作用及对小鼠骨髓细胞、水蚤的日光光毒性.结果：photofrinⅡ在250 nm-650 nm区间有多个吸收峰,在紫外光区有很强的吸收峰,而三种蛋白酶解产物的光谱较单一,其中R-PE β亚基、CCP1在可见光区有1～2较强的吸收峰;当光敏剂在瘤体旁注射量为50μg/个（瘤体）,He-Ne激光照射剂量为120 J/cm^2,瘤体大小在直径为0.5 cm～0.7 cm,phofofrinⅡ、CCP1、CCP3在照射后7天的抑瘤率分别为61%、46%及81%;用广谱性碘钨灯为光源,当光敏剂的浓度为100μg/mL,光照剂量为45 J/cm^2,photofrinⅡ对小鼠S180细胞及骨髓细胞的光敏杀伤作用分别为20%及33%,而RPE β亚基则分别为68%及95%;如果用100μg/mL的CCP1、CCP3、photofrinⅡ及不同照射剂量的碘钨灯为激发光源处理水蚤,结果发现,光毒性对水蚤生存率长短的影响具时间积累效应,在相同光照强度条件下,photofrinⅡ的光毒性最大,CCP3次之,CCP1最弱.结论：藻胆蛋白酶解产物R-PE β亚基、CCP1、CCP3光谱单一、PDT作用效果良好、毒副作用弱且具一定的荧光活性可作为新一代光敏剂选择的对象.     

低能量激光照射对小鼠脾脏NK细胞活性影响的试验研究

目的：研究能量激光照射对小鼠NK细胞活性的影响,以便从NK细胞活性的角度阐明其免疫调节效应。方法：以BALB／c小鼠为研究对象,应用7.337J/cm^2,11．00J/cm^2,14．67J/cm^2,22．00J/cm^2和36．67J/cm^2五种剂量的氦氖激光作小鼠内眼角照射,连续照射8d,并于照射开始后第3d,6d,9d,13d和第17d,动脉监测实验鼠脾脏NK细胞活性。结果：以日剂量为7.33J/cm^2,11.00J/cm^2,14.67J/cm^2和22.00J/cm^2LELI照射小鼠四个剂量组均可增强NL细胞的活性（P＜0．01或P＜0．05）,但其峰值的出现随着LELI剂量的增大而加快,22．00J/cm^2剂量组在第3d就达到峰值,而其余三组则分别在第9d或第13d时达到峰值,与相相反,大剂量36.6J/cm^2ELEI组NK活性则表现出明显的抑制效应。结论：适当剂量的低能量激光照射剂可对小鼠脾脏NK细胞活性产生增强效应,而过大剂是LELI则产生抑制效应。     

藻红蛋白亚基光敏剂对小鼠移植瘤作用的超微结构研究

目的：从形态学角度探讨藻红蛋白(R-PE)β亚基光动力学抗肿瘤效果及其作用机理。方法：用不同密度的波长为496nm的氩离子激光对S180小鼠移植瘤进行β亚基光动力学治疗,并对治疗后的瘤体进行透射电镜的形态学观察。结果：用100μg／m1的β亚基,在200J/cm2激光照射剂量条件下治愈了瘤体直径为0．5cm-0．7cm大小的小鼠移植瘤,发现瘤组织中引起细胞死亡的途经有差异,被PDT抑制的肿瘤内部细胞表现出典型的凋亡细胞特征。结论：R-PE β亚基具较强的光动力学抗肿瘤效果,光动力治疗机理可能涉及肿瘤内部细胞死亡主要是凋亡途径而瘤周为坏死,且与血管系统破坏及白细胞参与的抗炎症反应相关。     

脉冲Nd:YAG激光对单层KB细胞损伤效应的研究

目的：观察脉冲Nd：YAG激光照射体外单层培养KB细胞后的形态改变及损伤后HSP70,c-Fos的表达情况,初步探讨较强脉冲激光对细胞的损伤效应及损伤修复机制。方法：建立单层培养细胞的脉冲Nd：YAG激光损伤模型,每个脉冲能量密度为160J／cm^2～186J／cm^2或220J／cm^2～257J／cm^2,分别于照后即刻、2h和6h,用台盼蓝染色、TUNEL检测分析该激光对KB细胞的损伤特点,免疫组化法检测HSP70,c-Fos的表达水平。结果：当照射剂量为220J／ecm^2～257J／cm^2时,照后即刻,光斑中央细胞形态严重破坏,直接坏死;周围细胞形态未发生明显改变。2h后周围细胞TUNEL。着色也增强,呈强阳性。照后6h光斑中央及周围细胞着色均减弱。TUNEL着色区直径随时间先扩大后缩小。当照射剂量为160J／cm^2～186J／cm^2时,细胞内HSP70、c-Fos表达随时问先显著增强,而后减弱至正常。结论：脉冲Nd：YAG激光在所选剂量下,可以引起单层KB细胞的损伤,包括即刻坏死、延迟性死亡及可逆性损伤。HSP70、c-Fos的高表达说明它们在保护受损细胞、修复激光所致损伤中发挥重要作用。     

Ar+激光、Nd:YAG激光辐照亚心形扁藻生物学效应初探

采用Ar^＋激光（488 nm,照射时间分别为10 min、20 min、30 min）、Nd：YAG（1064 nm,照射时间为1 min、2 min、3 min）辐照扁藻,通过细胞计数以及扫描色素的吸收光谱研究激光辐照扁藻的生物效应.研究结果表明：非色素吸收峰的激光可以产生激光生物效应;不同波长,不同剂量的激光辐照扁藻可以表现出相类似的生物效应;Ar＋辐照20 min、Nd：YAG辐照2 min可以刺激扁藻生长,明显提高色素吸收光密度值,促进光合作用的进行.文中对不同激光辐照扁藻所产生的生物效应进行了比较和探讨.     

低强度激光照射对老龄小鼠的抗氧化系统的影响

目的：研究低强度激光照射对机体抗氧化系统的影响。方法：采用不同剂量的低强度He-Ne激光照射老龄小鼠肝区,照射后观察T－SOD,Cn-SOD,Mn-SOD,T-AO,GSH-PX,GSH,MDA等指标。结果：能量密度分别为2．48J／cm^2,12．48J／cm^2,18．72J／cm^2的低强度He-Ne激光可提高,Cu,Zn-SOD,Mn-SOD,总SOD,及GSH－PX活性,可提高GSH含量和总抗氧化能力,降低MDA含量,其中以能量密度为18．72J／cm^2最为显著,使老龄小鼠以上各项指标恢复接近正常水平。结论：低强度激光照射可以提高机体抗氧化酶的活性和抗氧化剂的含量,增强机体抗氧化能力。     

光动力疗法诱导增生滑膜细胞凋亡的初步研究

目的：观察光动力疗法（PDT）诱导类风湿性关节炎（RA）动物模型的增生滑膜细胞的凋亡情况。方法：兔AIA模型在关节类出现第七天进行PDT治疗,随机治疗一侧膝关节,另一侧作自身对照,免耳静脉注入HMME10mg/Kg,20分钟后,膝关节用金蒸气激光照射,激光波长627.8nm,功率密度100mW/cm^2,能量密度100J/cm^2,24小时后取膝关节滑膜作病理检查,并用脱氧核苷酸末端转移酶介导的缺口末端标记法（TUNEL）原位检测凋亡结论。结果：PDT治疗组凋亡阳性细胞较对照组明显增多,图像分析结果单位视野内阳性细胞数和面密度PDT治疗组高于对照组,统计学检验差异有显著性,凋亡细胞核直径PDT治疗组较小,与对照组相比,统计学检验差异有显著性。结论：PDT有可能通过诱发滑膜细胞的凋亡,使增生的滑膜细胞减少。     

藻蓝蛋白亚基细胞渗透性及对肿瘤细胞光敏作用的研究

目的:研究藻蓝蛋白亚基对SP2/0、S180、COS7、C6的最佳渗透条件及由其介导的PDT对肿瘤细胞的抑制作用。方法:采用柱层析方法从藻蓝蛋白样品中分离得到藻蓝蛋白亚基,通过荧光显微镜观察其在细胞内的渗透特性,并以He-Ne激光器为激发光源,MTT法检测藻蓝蛋白亚基光敏作用对肿瘤细胞生长的抑制作用。结果:藻蓝蛋白α、α/β亚基在75μg/mL浓度下可以在4 h时充分地进入细胞,并可以在细胞内稳定2 h以上;藻蓝蛋白中的α,β亚基稳定性和作用不相同,β亚基荧光性强但易于降解,由α亚基介导的PDT作用比α/βPDT作用强;100μg/mLα亚基介导的PDT对SP2/0和S180两种悬浮细胞的抑制率可分别达到78.6%和39.8%,强于贴壁细胞C6和COS7的29.2%和17.8%。结论:藻蓝蛋白α亚基在合适的渗透条件下表现出较强的光动力学抗肿瘤效果,且PDT效果与光敏剂浓度、照射剂量及细胞类型相关。     

藻蓝蛋白亚基脂质体光动力学抗乳腺癌细胞的实验研究

目的:研究PEG修饰的藻蓝蛋白亚基光敏剂长循环脂质体介导的光动力疗法抗乳腺癌的效果.方法:采用薄膜水合-超声分散法制备PEG修饰的藻蓝蛋白亚基脂质体(PEG-PCS-lip),MTT法检测藻蓝蛋白亚基脂质体对MCF-7(人乳腺癌细胞)、MA-782(鼠乳腺癌细胞)的光动力杀伤效果,流式细胞术(FCM)分析其对肿瘤细胞周期的影响,并对乳腺癌模型鼠做PDT治疗.结果:PEG-PCS-lip介导的PDT作用对乳腺癌细胞有良好的光动力疗效,对MCF-7及MA-782细胞IC_(50)(半数抑制浓度)分别为68 μg/mL、70 μg/mL;FCM的结果显示,当PEG-PCS-lip 浓度为50 μg/mL时,MCF-7凋亡率约为30.5 %; 用10 mg/kg PEG-PCS-lip静脉注射荷瘤小鼠,光照剂量为208.2 J/cm~2时,其抑瘤率可达到72 %;组织切片观察PDT作用后的肿瘤组织,瘤体中间以细胞凋亡为主,瘤体外周以细胞坏死为主,由血管损伤而形成的空腔增多.结论:PEG-PCS-lip在体外对乳腺癌细胞有良好的光动力杀伤效果,肿瘤细胞凋亡及瘤血管破坏是导致肿瘤细胞死亡的主要原因.     

658 nm低能量激光照射对人牙周膜细胞生物学效应的影响

目的:探讨658 nm低能量激光照射对人牙周膜细胞增殖、碱性磷酸酶活性及纤维连接蛋白合成的影响.方法:改良组织块法体外培养人牙周膜细胞.通过658 nm激光照射人牙周膜细胞,观察能量密度为1.86 J/cm2和3.72 J/cm2激光照射后不同时间点细胞增殖效应、碱性磷酸酶活性和纤维连接蛋白的变化.结果:1.86 J/cm2和3.72 J/cm2能量密度的激光照射人牙周膜细胞,可显著促进细胞增殖效应.3.72 J/cm2能量密度的激光照射可提高人牙周膜细胞碱性磷酸酶活性;能量密度为1.86 J/cm2的激光照射人牙周膜细胞72 h后,细胞中纤维连接蛋白分泌量增加.结论:658 nm低剂量激光照射可促进人牙周膜细胞增殖;适量的低剂量激光照射人牙周膜细胞可促进其碱性磷酸酶活性及纤维连接蛋白的分泌.     

C_(60)对小鼠S_(180)肉瘤光动力学作用模型的建立

为验证Ｃ６０对活体肿瘤的光动力学损伤作用,我们从两方面进行实验：Ｃ６０对荷瘤小鼠的Ｓ１８０实体瘤的光动力学杀伤作用和Ｃ８０对离体Ｓ１８０肿瘤细胞的光动力学杀伤作用,在小鼠的瘤体上注射Ｃ８０光敏剂,在５１１ｎｍ、５７８ｎｍ混合黄录色激光照射正派主发Ｃ６０,产生大量的单线态氧,杀伤活性肿瘤。激光光强为５００ｍＷ,Ｃ６０浓度为３０μｇ／ｍｌ时,荷瘤小鼠寿命平均延长５天,瘤径减小１ｃｍ,瘤重减轻０．８克,     

Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis.

Osteomyelitis can lead to severe morbidity and even death resulting from an acute or chronic inflammation of the bone and contiguous structures due to fungal or bacterial infection. Incidence approximates 1 in 1000 neonates and 1 in 5000 children in the United States annually and increases up to 0.36% and 16% in adults with diabetes or sickle cell anaemia, respectively. Current regimens of treatment include antibiotics and/or surgery. However, the increasing number of antibiotic resistant pathogens suggests that alternate strategies are required. We are investigating photodynamic therapy (PDT) as one such alternate treatment for osteomyelitis using a bioluminescent strain of biofilm-producing staphylococcus aureus (S. aureus) grown onto kirschner wires (K-wire). S. aureus-coated K-wires were exposed to methylene blue (MB) or 5-aminolevulinic acid (ALA)-mediated PDT either in vitro or following implant into the tibial medullary cavity of Sprague-Dawley rats. The progression of S. aureus biofilm was monitored non-invasively using bioluminescence and expressed as a percentage of the signal for each sample immediately prior to treatment. S. aureus infections were subject to PDT 10 days post inoculation. Treatment comprised administration of ALA (300 mg kg(-1)) intraperitoneally followed 4 h later by light (635 +/- 10 nm; 75 J cm(-2)) delivered transcutaneously via an optical fiber placed onto the tibia and resulted in significant delay in bacterial growth. In vitro, MB and ALA displayed similar cell kill with > or =4 log(10) cell kill. In vivo, ALA-mediated PDT inhibited biofilm implants in bone. These results confirm that MB or ALA-mediated PDT have potential to treat S. aureus cultures grown in vitro or in vivo using an animal model of osteomyelitis.     

Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing

The in vivo antitumour activity of the natural photosensitizer hypericin was evaluated. C3H/DiSn mice were inoculated with fibrosarcoma G5:1:13 cells. When the tumour reached a volume of 40-80mm3 the mice were intraperitoneally injected with hypericin, either in a single dose (5mg/kg; 1 or 6h before laser irradiation) or two fractionated doses (2.5 mg/kg; 6 and 1 h before irradiation with laser light; 532 nm, 70mW/cm2, 168 J/cm2). All tumours in control groups treated with hypericin alone as well as those irradiated with laser light alone had similar growth rates and none of these tumours regressed spontaneously. Complete remission of tumour in photodynamic therapy (PDT)-treated groups was similar (14-17% single dose vs. 33% fractionated dose), but the fractionated schedule of hypericin dosing was found to be more efficient than the single dose, measured by survival assay (p < 0.05). Our experimental model showed that fractionated administration of hypericin can produce a better therapeutic response than single administration.     

贝伐单抗对ALA—PDT诱导的新生血管形成和胶质瘤生长的影响

探讨贝伐单抗对低剂量5-氨基乙酰丙酸（5-Aminolevulinicacid,ALA）介导的光动力学疗法（photodynamic therapy,PDT）诱导的脑组织新生血管形成和U87脑胶质瘤生长的影响。通过将裸小鼠随机分为对照组、ALA．PDT预处置组（ALA：2．3×10-3mol／kg,能量密度：10J／cm2）、贝伐单抗预处置组（1．6×10-5mol／kg）和联合预处置组（ALA—PDT＋贝伐单抗）,并接受相应处置。第10d,检测PDT照射及相应区域内新生血管形成和VEGF表达并种植U87脑胶质瘤细胞,21d后观察肿瘤体积。与对照组比较,低剂量ALA-PDT预处置后新生血管增多、VEGF表达增高,肿瘤体积增大,这些变化在联合预处置组被抑制;贝伐单抗预处置组的血管形态和VEGF表达虽无明显变化,但肿瘤体积减小。研究结果表明低剂量ALA-PDT可通过刺激VEGF表达诱导照射区新生血管形成,这种微环境的改变有利于U87胶质瘤细胞生长,但这些作用可被贝伐单抗所抑制。     

Dose-dependent metabolic response of mammary carcinoma to photodynamic therapy

The metabolic response of mammary carcinoma in the C3H mouse to photodynamic therapy (PDT) was measured using in vivo 31P nuclear magnetic resonance (31P-NMR) spectroscopy and pH microelectrodes. Twenty-four hours after administration of Photofrin II (12.5 mg/kg), the tumor was subjected to photoactivation using an argon dye laser. Optical treatment doses were 200, 400, and 600 J/cm2 and corresponded to the following tumor control doses: TCD10/30, TCD50/30, and TCD90/30, respectively. In vivo 31P-NMR spectra and pH micro-electrode measurements were obtained prior to treatment and at 4, 24, 48, and 72 h and 1 week post-treatment. The data revealed a significant (P less than 0.0002) alkalosis as indicated by the pH measured by NMR compared to pH measured by microelectrodes at all treatment levels and time points. Spectral differences between treatment groups were apparent as early as 4 h after treatment. The ratio of beta-nucleoside triphosphate to inorganic phosphate at 4 h after treatment was significantly (P less than 0.01) smaller for 600 J/cm2 treatment than for 200 J/cm2 treatment. At curative (600 J/cm2) levels, from 48 h on, no phosphate resonances were detected in the spectra. The pH measured by NMR transiently decreased from pretreatment levels after 200 and 400 J/cm2 treatment (P less than 0.002, P less than 0.009, respectively), while no change in pH from pretreatment values was found after 600 J/cm2 treatment. The data suggest that the early metabolic response of mammary carcinoma to PDT, as indicated by 31P-NMR spectroscopy, is dose dependent, and may be a sensitive indicator of biological outcome to treatment.     

Photosensitizers related to purpurin-18-N-alkylimides: a comparative in vivo tumoricidal ability of ester versus amide functionalities

For a comparative study, 3-(alkyloxyethyl)-3-devinylpurpurin-18-N-hexylimides with ester and amide functionalities were investigated for tumor selectivity and in vivo photosensitizing efficacy. Compared to amide analogues, the related photosensitizers with ester functionalities were found to be more effective. Among these compounds the 3-devinyl-(3-hexyloxyethyl)-purpurin-18-N-hexylimide as methyl ester 12 showed excellent tumor uptake (tumor versus muscle ratio: 8:1), and produced 100% tumor cure on day 30 at a dose of 1.0 micromol/kg. The mice were treated with light (135 J/cm2, 705 nm) at 24 h post injection of the drug.     

西南银莲花皂苷的抗肿瘤作用

目的：对西南银莲花中抑制人癌细胞生长的主要活性成分3－O－鼠李糖基（2）[葡萄糖基（4）]阿拉伯糖基－齐墩果酸（皂苷2）等进行动物体内抗癌活性试验研究。方法：用小鼠肉瘤S180实体模型观测腹腔注射和灌服两种给药途径的抑瘤率,结果:ip皂苷2为10mg/kg时抑瘤率为48．9％,po皂苷2为125,200和500mg/kg时抑瘤率分别为32．6％,39．3％和48．1％,但均不同程度地出现动物死亡,结论：不论腹腔注射[还是灌服给药,皂苷2对小鼠肉瘤S180生长均具有一定的抑制作用,但在有效剂量下已表现出一定的毒性。     

藻蓝蛋白亚基脂质体光动力作用对LKB1在乳腺癌细胞中表达的影响

为了探讨肿瘤抑制因子LKB1蛋白在肿瘤光动力疗法中作用,先用MTT法检测藻蓝蛋白亚基脂质体（PEG-PCS-Lip）对人乳腺癌细胞MCF-7,鼠乳腺癌细胞MA-782的光动力杀伤效果,分光光度法检测活性氧ROS的产量,Western blot检测LKB1激酶表达水平;然后用免疫组织化学方法观察PEG-PCS-Lip介导的光动力作用在乳腺癌模型鼠对LKB1基因表达影响. 结果显示在光照剂量为29.17 J/cm2时,用0~25 μg/mL PEG-PCS-Lip处理会小幅度促进MA-782和MCF-7细胞的生长,同时细胞中的ROS和LKB1蛋白的量下降;当用25~100 μg/mL PEG-PCS-Lip处理则明显抑制MA-782和MCF-7细胞的生长,同时细胞中的ROS和LKB1蛋白的量随PEG-PCS-Lip量的增加而增加.用10 mg/kg PEG-PCS-Lip静脉注射荷瘤小鼠,光照剂量为208.2 J/cm2时,其抑瘤率可达到68.9 %,LKB1在乳腺癌组织中的表达量则增加了33.9 %,同时,LKB1激酶从细胞核转移到细胞质的量也在增加. 因此,PEG-PCS-Lip PDT作用所产生的ROS可能是激活LKB1的表达的原因之一,二者协同作用在一定的光敏剂浓度范围内增强了PDT抑制肿瘤生长的疗效.